Cite
HARVARD Citation
Mazepa, M. et al. (n.d.). Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura. British journal of haematology. pp. 900-902. [Online].